Enhanced T cell-mediated protection against malaria in human challenges by using the recombinant poxviruses FP9 and modified vaccinia virus Ankara (Q33935092)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Enhanced T cell-mediated protection against malaria in human challenges by using the recombinant poxviruses FP9 and modified vaccinia virus Ankara	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

30 July 2017

Enhanced T cell-mediated protection against malaria in human challenges by using the recombinant poxviruses FP9 and modified vaccinia virus Ankara (English)

1 reference

Europe PubMed Central

30 July 2017

0 references

object named as

vaccinia virus

1 reference

based on heuristic

inferred from title

15

1 reference

Europe PubMed Central

30 July 2017

Stephen M Laidlaw

object named as

Stephen M Laidlaw

6

0 references

Samuel J McConkey

object named as

Samuel J McConkey

7

0 references

Michael A. Skinner

object named as

Michael A Skinner

14

0 references

object named as

Sheila Keating

5

0 references

11

object named as

Philip Bejon

1 reference

Europe PubMed Central

30 July 2017

Adrian V. S. Hill

16

object named as

Adrian V S Hill

1 reference

Europe PubMed Central

30 July 2017

Susanna Dunachie

object named as

Susanna Dunachie

2

0 references

Tamara Berthoud

4

object named as

Tamara Berthoud

1 reference

Europe PubMed Central

30 July 2017

8

object named as

Ian Poulton

1 reference

Europe PubMed Central

30 July 2017

3

object named as

Jenni M Vuola

1 reference

Europe PubMed Central

30 July 2017

12

object named as

Geoff Butcher

1 reference

Europe PubMed Central

30 July 2017

Robert E Sinden

13

object named as

Robert Sinden

1 reference

Europe PubMed Central

30 July 2017

author name string

Daniel P Webster

1

1 reference

Europe PubMed Central

30 July 2017

Laura Andrews

9

1 reference

Europe PubMed Central

30 July 2017

Rikke F Andersen

10

1 reference

Europe PubMed Central

30 July 2017

language of work or name

0 references

publication date

21 March 2005

1 reference

Europe PubMed Central

30 July 2017

number of pages

6

1 reference

based on heuristic

inferred from page(s)

Proceedings of the National Academy of Sciences of the United States of America

1 reference

Europe PubMed Central

30 July 2017

102

1 reference

Europe PubMed Central

30 July 2017

13

1 reference

Europe PubMed Central

30 July 2017

4836-4841

1 reference

Europe PubMed Central

30 July 2017

Calculation of liver-to-blood inocula, parasite growth rates, and preerythrocytic vaccine efficacy, from serial quantitative polymerase chain reaction studies of volunteers challenged with malaria sporozoites

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=555695

28 July 2018

Differential immunogenicity of various heterologous prime-boost vaccine regimens using DNA and viral vectors in healthy volunteers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=555695

28 July 2018

Comparison of the genome sequence of FP9, an attenuated, tissue culture-adapted European strain of Fowlpox virus, with those of virulent American and European viruses

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=555695

28 July 2018

A Plasmodium falciparum candidate vaccine based on a six-antigen polyprotein encoded by recombinant poxviruses

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=555695

28 July 2018

Protection of humans against malaria by immunization with radiation-attenuated Plasmodium falciparum sporozoites

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=555695

28 July 2018

Induction of CD4(+) T cell-dependent CD8(+) type 1 responses in humans by a malaria DNA vaccine.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=555695

28 July 2018

Multistage multiantigen heterologous prime boost vaccine for Plasmodium knowlesi malaria provides partial protection in rhesus macaques

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=555695

28 July 2018

Enhanced immunogenicity of CD4(+) t-cell responses and protective efficacy of a DNA-modified vaccinia virus Ankara prime-boost vaccination regimen for murine tuberculosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=555695

28 July 2018

Development of a preventive vaccine for Ebola virus infection in primates

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=555695

28 July 2018

Effective induction of simian immunodeficiency virus-specific cytotoxic T lymphocytes in macaques by using a multiepitope gene and DNA prime-modified vaccinia virus Ankara boost vaccination regimen

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=555695

28 July 2018

Enhanced T-cell immunogenicity and protective efficacy of a human immunodeficiency virus type 1 vaccine regimen consisting of consecutive priming with DNA and boosting with recombinant fowlpox virus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=555695

28 July 2018

Long-term efficacy and immune responses following immunization with the RTS,S malaria vaccine.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=555695

28 July 2018

Boosting with recombinant vaccinia increases immunogenicity and protective efficacy of malaria DNA vaccine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=555695

28 July 2018

Enhanced immunogenicity for CD8+ T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=555695

28 July 2018

Heterologous protection against influenza by injection of DNA encoding a viral protein

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=555695

28 July 2018

Active immunotherapy of cancer with a nonreplicating recombinant fowlpox virus encoding a model tumor-associated antigen

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=555695

28 July 2018

Attenuation of virulent fowl pox virus in tissue culture and characteristics of the attenuated virus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=555695

28 July 2018

Vaccinia virus expression vector: coexpression of beta-galactosidase provides visual screening of recombinant virus plaques

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=555695

28 July 2018

Malaria transmitted to humans by mosquitoes infected from cultured plasmodium falciparum

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=555695

28 July 2018

Protective immunity against avian influenza induced by a fowlpox virus recombinant

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=555695

28 July 2018

Recombinant fowlpox virus inducing protective immunity in non-avian species

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=555695

28 July 2018

Fowlpox virus as a vector in non-avian species

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=555695

28 July 2018

Experimental basis for the development of a synthetic vaccine against Plasmodium falciparum malaria sporozoites

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=555695

28 July 2018

Successful immunization of humans with irradiated malaria sporozoites: humoral and cellular responses of the protected individuals

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=555695

28 July 2018

Common west African HLA antigens are associated with protection from severe malaria

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=555695

28 July 2018

The complexity of protective immunity against liver-stage malaria

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.0406381102

21 January 2018

Induction of antigen-specific cytotoxic T lymphocytes in humans by a malaria DNA vaccine.

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.0406381102

21 January 2018

Enhanced T-cell immunogenicity of plasmid DNA vaccines boosted by recombinant modified vaccinia virus Ankara in humans

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.0406381102

21 January 2018

Efficacy of RTS,S/AS02 malaria vaccine against Plasmodium falciparum infection in semi-immune adult men in The Gambia: a randomised trial

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.0406381102

21 January 2018

Enhanced CD8+ T cell immune responses and protection elicited against Plasmodium berghei malaria by prime boost immunization regimens using a novel attenuated fowlpox virus

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.0406381102

21 January 2018

Phase I/IIa safety, immunogenicity, and efficacy trial of NYVAC-Pf7, a pox-vectored, multiantigen, multistage vaccine candidate for Plasmodium falciparum malaria.

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.0406381102

21 January 2018

A protein particle vaccine containing multiple malaria epitopes.

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.0406381102

21 January 2018

Efficacy of the RTS,S/AS02A vaccine against Plasmodium falciparum infection and disease in young African children: randomised controlled trial

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.0406381102

21 January 2018

Evolution of epitope-specific memory CD4(+) T cells after clearance of hepatitis C virus.

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.0406381102

21 January 2018

A CD4(+) T-cell immune response to a conserved epitope in the circumsporozoite protein correlates with protection from natural Plasmodium falciparum infection and disease

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.0406381102

21 January 2018

Opsonization by antigen-specific antibodies as a mechanism of protective immunity induced by Plasmodium falciparum circumsporozoite protein-based vaccine.

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.0406381102

21 January 2018

Protective immunity induced with malaria vaccine, RTS,S, is linked to Plasmodium falciparum circumsporozoite protein-specific CD4+ and CD8+ T cells producing IFN-gamma.

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.0406381102

21 January 2018

Phase 1 evaluation of 3 highly immunogenic prime-boost regimens, including a 12-month reboosting vaccination, for malaria vaccination in Gambian men.

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.0406381102

21 January 2018

Population dynamics of untreated Plasmodium falciparum malaria within the adult human host during the expansion phase of the infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=555695

29 October 2018

Enhancing the recognition of tumour associated antigens.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=555695

29 October 2018

Polymorphism of the TRAP gene of Plasmodium falciparum

1 reference

https://pubmed.ncbi.nlm.nih.gov/15781866

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A recombinant avipoxvirus HIV-1 vaccine expressing interferon-gamma is safe and immunogenic in macaques

1 reference

https://pubmed.ncbi.nlm.nih.gov/15781866

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

WHO Expert Committee on Malaria

1 reference

https://pubmed.ncbi.nlm.nih.gov/15781866

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Synergy of vaccine strategies to amplify antigen-specific immune responses and antitumor effects

1 reference

https://pubmed.ncbi.nlm.nih.gov/15781866

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1073/PNAS.0406381102

1 reference

Europe PubMed Central

30 July 2017

2005PNAS..102.4836W

0 references

1 reference

Europe PubMed Central

30 July 2017

1 reference

Europe PubMed Central

30 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33935092&oldid=1968147651"